Hospitals are adding more connected devices than ever before—from patient wearables to asset tracking systems. Yet this digital transformation is being bottlenecked by an antiquated power infrastructure dependent on single-use batteries that create waste, demand constant maintenance, and compromise device reliability.
Transaction Expected to Help Hologic Strengthen its Leadership in Women’s Health and Accelerate Growth
Survey will assess demographics, salary rates, more.
Asset acquisition expected to expand Merit’s Endoscopy portfolio with an innovative device to treat patients suffering from Barretts esophagus and other gastrointestinal disorders.
Boston Sci acquisition expected to expand the neuromodulation offerings for people living with chronic pain.
GLD Announces Successful Closing of Seelos Assets; Includes Ketamine and Trehalose Programs Advancing into Phase 3 Clinical Trials.
The physician has a unique perspective that non-clinical investors don’t: they know firsthand whether a technology will be adopted. They deeply understand if it truly is better for them and their patients.
Originally CE marked in 2021 for limited to high-risk patients only, .Abbott has now received CE mark approval for its Navitor transcatheter aortic valve replacement (TAVR) system to treat low- and intermediate-risk patients with symptomatic, severe aortic stenosis.
A comprehensive update on the combination products market shows significant industry partnerships, development challenges, and strategic imperatives for success in the sector characterized by dynamic collaboration between pharmaceutical and device companies, rapid product development cycles, and complex regulatory landscapes.
Shift Left, an approach to revenue cycle, may help clinics reimagine billing – not as a back-end cleanup job, but as something solved upstream at registration, like eligibility checks and authorizations – before a single claim is ever submitted. Are fewer denials, faster payments, and stronger financial footing possible for clinics already stretched thin?
